The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease

Accumulated evidence suggests that an altered ambulatory blood pressure (BP) profile, particularly elevated nighttime BP, reflects target organ injury and is a better predictor of further cardiorenal risk than the clinic BP or daytime BP in hypertensive patients complicated by chronic kidney disease...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Yanagi, Mai, Tamura, Kouichi, Fujikawa, Tetsuya, Wakui, Hiromichi, Kanaoka, Tomohiko, Ohsawa, Masato, Azushima, Kengo, Maeda, Akinobu, Kobori, Hiroyuki, Umemura, Satoshi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2012
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3594468/
https://ncbi.nlm.nih.gov/pubmed/23154587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/hr.2012.184
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg